Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2731]

Gene signature found for poor response to standard chemotherapy in rare uterine cancer

Gene signature found for poor response to standard chemotherapy in rare uterine cancer

Nutrient deficiency in tumour cells attracts cells that suppress the immune system

Nutrient deficiency in tumour cells attracts cells that suppress the immune system

COVID-19 and cancer: Can innovative technologies support individual patient needs? - Blog post by Dr Vineet Datta

COVID-19 and cancer: Can innovative technologies support individual patient needs? - Blog post by Dr Vineet Datta

FDA approves tucatinib in combination with chemotherapy for patients with HER2-positive metastatic breast cancer

FDA approves tucatinib in combination with chemotherapy for patients with HER2-positive metastatic breast cancer

Drug overcomes chemotherapy resistance in ovarian cancer

Drug overcomes chemotherapy resistance in ovarian cancer

FDA approves mitomycin for low-grade upper tract urothelial cancer

FDA approves mitomycin for low-grade upper tract urothelial cancer

Study reveals how 'hypermutated' malignant brain tumours escape chemotherapy and immunotherapy

Study reveals how 'hypermutated' malignant brain tumours escape chemotherapy and immunotherapy

Immunotherapy treatment after chemotherapy significantly slows metastatic bladder cancer

Immunotherapy treatment after chemotherapy significantly slows metastatic bladder cancer

TAILORx dispels chemo-brain notion: Women on hormone therapy also report cognitive decline

TAILORx dispels chemo-brain notion: Women on hormone therapy also report cognitive decline

NYU Abu Dhabi researchers synthesise gold nanoparticles capable of attacking cancer cells

NYU Abu Dhabi researchers synthesise gold nanoparticles capable of attacking cancer cells

More from ecancer